Company / Operating Cash Flow per Share
ARS Pharmaceuticals, Inc. Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.74
FY2025
5-year range
-$1.74 / $0.14
FY2021-FY2025
Trend
-1341.4%
vs FY2024
Sector context
#140 of 212
Health Care
What the data says
Operating Cash Flow per Share changed -1341% YoY in FY2025, a notable deviation from the 5-year average annual change of -226%.
Based on SEC 10-K filings.
-1.74 in FY2025.
Declined from $-0.63 to $-1.74 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#140 of 212 in Health CareTop 66% of 212This company -$1.74 Sector average -$14.72
▼
+88.2% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 1341.4% year-over-year.
- Ranks #140 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.74 | -1341.4% |
| FY2024 | $0.14 | +122.3% |
| FY2023 | -$0.63 | -9.1% |
| FY2022 | -$0.58 | +4.9% |
| FY2021 | -$0.61 | +94.3% |
| FY2020 | -$10.73 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026